Why Halozyme, An IBD 50 Stock, Just Hit A Record High In Bullish Volume

Halozyme stock rocketed to a record high Friday as its newer Enhanze-tied products start driving incremental growth. The post Why Halozyme, An IBD 50 Stock, Just Hit A Record High In Bullish Volume appeared first on Investor's Business Daily.

CryptoAlerta — análise de criptomoedas e mercado em tempo real